Characterisation of L-Type Amino Acid Transporter 1 (LAT1) Expression in Human Skeletal Muscle by Immunofluorescent Microscopy

被引:32
|
作者
Hodson, Nathan [1 ]
Brown, Thomas [1 ]
Joanisse, Sophie [1 ]
Aguirre, Nick [2 ]
West, Daniel W. D. [3 ]
Moore, Daniel R. [3 ]
Baar, Keith [2 ]
Breen, Leigh [1 ]
Philp, Andrew [1 ]
机构
[1] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham B15 2TT, W Midlands, England
[2] Univ Calif Davis, Davis, CA 95616 USA
[3] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON M5S 1A1, Canada
来源
NUTRIENTS | 2018年 / 10卷 / 01期
基金
英国生物技术与生命科学研究理事会;
关键词
LAT1; leucine; protein; amino acid transport; BLOOD-BRAIN-BARRIER; RESISTANCE EXERCISE; ENDURANCE EXERCISE; PROTEIN-SYNTHESIS; PLASMA-MEMBRANE; GENE-EXPRESSION; IN-VIVO; GROWTH; CELLS; AVAILABILITY;
D O I
10.3390/nu10010023
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The branch chain amino acid leucine is a potent stimulator of protein synthesis in skeletal muscle. Leucine rapidly enters the cell via the L-Type Amino Acid Transporter 1 (LAT1); however, little is known regarding the localisation and distribution of this transporter in human skeletal muscle. Therefore, we applied immunofluorescence staining approaches to visualise LAT1 in wild type (WT) and LAT1 muscle-specific knockout (mKO) mice, in addition to basal human skeletal muscle samples. LAT1 positive staining was visually greater in WT muscles compared to mKO muscle. In human skeletal muscle, positive LAT1 staining was noted close to the sarcolemmal membrane (dystrophin positive staining), with a greater staining intensity for LAT1 observed in the sarcoplasmic regions of type II fibres (those not stained positively for myosin heavy-chain 1, Type II25.07 +/- 5.93, Type I13.71 +/- 1.98, p < 0.01), suggesting a greater abundance of this protein in these fibres. Finally, we observed association with LAT1 and endothelial nitric oxide synthase (eNOS), suggesting LAT1 association close to the microvasculature. This is the first study to visualise the distribution and localisation of LAT1 in human skeletal muscle. As such, this approach provides a validated experimental platform to study the role and regulation of LAT1 in human skeletal muscle in response to various physiological and pathophysiological models.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer
    Kurozumi, Sasagu
    Kaira, Kyoichi
    Matsumoto, Hiroshi
    Kurosumi, Masafumi
    Yokobori, Takehiko
    Kanai, Yoshikatsu
    Sekine, Chikako
    Honda, Chikako
    Katayama, Ayaka
    Furuya, Mio
    Shiino, Sho
    Makiguchi, Takaya
    Mongan, Nigel P.
    Rakha, Emad A.
    Oyama, Tetsunari
    Fujii, Takaaki
    Shirabe, Ken
    Horiguchi, Jun
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [42] Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer
    Sasagu Kurozumi
    Kyoichi Kaira
    Hiroshi Matsumoto
    Masafumi Kurosumi
    Takehiko Yokobori
    Yoshikatsu Kanai
    Chikako Sekine
    Chikako Honda
    Ayaka Katayama
    Mio Furuya
    Sho Shiino
    Takaya Makiguchi
    Nigel P. Mongan
    Emad A. Rakha
    Tetsunari Oyama
    Takaaki Fujii
    Ken Shirabe
    Jun Horiguchi
    Scientific Reports, 12
  • [43] Structure-activity relationship of a novel series of inhibitors for cancer type transporter L-type amino acid transporter 1 (LAT1)
    Kongpracha, Pornparn
    Nagamori, Shushi
    Wiriyasermkul, Pattama
    Tanaka, Yoko
    Kaneda, Kazuko
    Okuda, Suguru
    Ohgaki, Ryuichi
    Kanai, Yoshikatsu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 133 (02) : 96 - 102
  • [44] Pharmacokinetic role of L-type amino acid transporters LAT1 and LAT2
    del Amo, Eva M.
    Urtti, Atto
    Yliperttula, Marjo
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 35 (03) : 161 - 174
  • [45] Prognostic Value of L-Type Amino Acid Transporter 1 (LAT1) in Various Cancers: A Meta-Analysis
    Zhang, Chuanmeng
    Xu, Jie
    Xue, Shanshan
    Ye, Jun
    MOLECULAR DIAGNOSIS & THERAPY, 2020, 24 (05) : 523 - 536
  • [46] L-type amino acid transporter 1 (LAT1): A new therapeutic target for canine mammary gland tumour
    Fukumoto, Shinya
    Hanazono, Kiwamu
    Komatsu, Takahiro
    Ueno, Hiroshi
    Kadosawa, Tsuyoshi
    Iwano, Hidetomo
    Uchide, Tsuyoshi
    VETERINARY JOURNAL, 2013, 198 (01): : 164 - 169
  • [47] Gene expression profiles in t24 human bladder carcinoma cells by inhibiting an l-type amino acid transporter, lat1
    Shadi Baniasadi
    Arthit Chairoungdua
    Yuji Iribe
    Yoshikatsu Kanai
    Hitoshi Endou
    Ken-ichi Aisaki
    Katsuhide Igarashi
    Jun Kanno
    Archives of Pharmacal Research, 2007, 30 : 444 - 452
  • [48] Gene expression profiles in T24 human bladder carcinoma cells by inhibiting an L-type amino acid transporter, LAT1
    Baniasadi, Shadi
    Chairoungdua, Arthit
    Iribe, Yuji
    Kanai, Yoshikatsu
    Endou, Hitoshi
    Aisaki, Ken-ichi
    Igarashi, Katsuhide
    Kanno, Jun
    ARCHIVES OF PHARMACAL RESEARCH, 2007, 30 (04) : 444 - 452
  • [49] High expression of L-type amino-acid transporter 1 (LAT1) in gastric carcinomas: Comparison with non-cancerous lesions
    Ichinoe, Masaaki
    Mikami, Tetuo
    Yoshida, Tsutomu
    Igawa, Ikuyo
    Tsuruta, Tomoko
    Nakada, Norihiro
    Anzai, Naohiko
    Suzuki, Yoshiyuki
    Endou, Hitoshi
    Okayasu, Isao
    PATHOLOGY INTERNATIONAL, 2011, 61 (05) : 281 - 289
  • [50] Dual affinities of antibodies against L-type amino acid transporter 1 (LAT1) against CD98-LAT1 complex
    Ueda, Shiho
    Yamasaki, Akitaka
    Masuko, Takashi
    CANCER SCIENCE, 2018, 109 : 1060 - 1060